Skip to main content
. Author manuscript; available in PMC: 2022 May 23.
Published in final edited form as: Hypertension. 2021 Aug 11;78(3):644–646. doi: 10.1161/HYPERTENSIONAHA.121.17595

Table 1.

Classification of blood-brain barrier (BBB) crossing potential of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors by Ho et al.1

Drug Class Non-BBB-crossing BBB-crossing

ARB Olmesartan
Eprosartan
Irbesartan
Losartan
Telmisartan
Candesartan

ACE
inhibitor
Benazepril
Enalapril
Moexipril
Quinapril
Captopril
Fosinopril
Lisinopril
Perindopril
Ramipril
Trandolapril